Showing BioInteractions for Lutetium Lu 177 dotatate (DB13985)
BioInteractor utilizes data on drug-target, -enzyme and -transporter associations to provide insight on drug-drug interactions. It allows you to identify, for instance, which drugs act similarly on the same target. Such drugs may have additive pharmacodynamic effects if given concomitantly. Conversely, two drugs may antagonize the beneficial effects of each other by having opposite actions on a specific drug target. BioInteractor uses ranked drug-enzyme association information to predict enzyme-mediated drug interactions that may be clinically relevant.
Interacting Group | Interacting Drugs | |
---|---|---|
Lutetium Lu 177 dotatate is a Somatostatin receptor type 2 agonist | ||
1 | Somatostatin receptor type 2 inducers | Vapreotide |
2 | Somatostatin receptor type 2 agonists | Lanreotide, Somatostatin |
3 | Somatostatin receptor type 2 binders | Copper oxodotreotide Cu-64, Dotatate gallium Ga-68 |
4 | Somatostatin receptor type 2 ligands | Edotreotide gallium Ga-68 |
Interacting Group | Interacting Drugs | |
---|---|---|
Lutetium Lu 177 dotatate is a Somatostatin receptor type 1 agonist | ||
1 | Somatostatin receptor type 1 agonists | Somatostatin |
2 | Somatostatin receptor type 1 ligands | Edotreotide gallium Ga-68 |
Interacting Group | Interacting Drugs | |
---|---|---|
Lutetium Lu 177 dotatate is a Somatostatin receptor type 3 agonist | ||
1 | Somatostatin receptor type 3 agonists | Somatostatin |
2 | Somatostatin receptor type 3 ligands | Edotreotide gallium Ga-68 |
Interacting Group | Interacting Drugs | |
---|---|---|
Lutetium Lu 177 dotatate is a Somatostatin receptor type 4 agonist | ||
1 | Somatostatin receptor type 4 agonists | Somatostatin |
Interacting Group | Interacting Drugs | |
---|---|---|
Lutetium Lu 177 dotatate is a Somatostatin receptor type 5 agonist | ||
1 | Somatostatin receptor type 5 agonists | Lanreotide, Somatostatin, Vapreotide |
2 | Somatostatin receptor type 5 ligands | Edotreotide gallium Ga-68 |